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O B J E C T I V E S We sought to evaluate radiofrequency (RF) ablation lesions in atrial ﬁbrillation
(AF) patients using cardiac magnetic resonance (CMR), and to correlate the ablation patterns with
treatment success.
B A C KG ROUND RF ablation procedures for treatment of AF result in localized scar that is detected
by late gadolinium enhancement (LGE) CMR. We hypothesized that the extent of scar in the left atrium
and pulmonary veins (PV) would correlate with moderate-term procedural success.
METHOD S Thirty-ﬁve patients with AF, undergoing their ﬁrst RF ablation procedure, were studied.
The RF ablation procedure was performed to achieve bidirectional conduction block around each PV
ostium. AF recurrence was documented using a 7-day event monitor at multiple intervals during the ﬁrst
year. High spatial resolution 3-dimensional LGE CMR was performed 46  28 days after RF ablation. The
extent of scarring around the ostia of each PV was quantitatively (volume of scar) and qualitatively
(1: minimal, 3: extensive and circumferential) assessed.
R E S U L T S Thirteen (37%) patients had recurrent AF during the 6.7  3.6-month observation period.
Paroxysmal AF was a strong predictor of nonrecurrent AF (15% with recurrence vs. 68% without, p 
0.002). Qualitatively, patients without recurrence had more completely circumferentially scarred veins
(55% vs. 35% of veins, p  NS). Patients without recurrence more frequently had scar in the inferior
portion of the right inferior pulmonary vein (RIPV) (82% vs. 31%, p  0.025, Bonferroni corrected). The
volume of scar in the RIPV was quantitatively greater in patients without AF recurrence (p  0.05) and
was a univariate predictor of recurrence using Cox regression (p  0.049, Bonferroni corrected).
CONC L U S I O N S Among patients undergoing PV isolation, AF recurrence during the ﬁrst year is
associated with a lesser degree of PV and left atrial scarring on 3-dimensional LGE CMR. This ﬁnding was
signiﬁcant for RIPV scar and may have implications for the procedural technique used in PV isolation. (J Am
Coll Cardiol Img 2009;2:308–16) © 2009 by the American College of Cardiology Foundation
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309ong-term success of catheter ablation for treat-
ment of atrial fibrillation (AF) remains 60% to
80% (1–4). The goal of the most commonly used
procedure electrically isolates the antrum of
ach pulmonary vein (PV) through an anatomically
omplete circumferential ablation. Recurrence of AF
as been attributed to incomplete circumferential or
ransmural ablation of the PV ostia leading to
econduction (5) and to the existence of other
See page 317
triggers beyond the PVs (6). Imaging can contrib-
ute to the understanding of PV isolation therapy by
visualizing the lesions that are created during cath-
eter ablation (7–11). To exploit this capability,
there are ongoing efforts to perform ablations under
the guidance of cardiac magnetic resonance (CMR)
or cardiac computed tomography (12,13).
Not all PVs are equal as sources of AF or as targets
for therapy. The upper PVs have the greatest propor-
tion of AF triggers (14,15) and the greatest proportion
of reconnected veins on follow-up (6). This reconnec-
tion may be caused by less well-ablated PVs during the
procedure. There are fewer triggers in the left inferior
pulmonary vein (LIPV) (14,15), but a lower rate of
reconnection is found (6) during a repeat catheter
ablation procedure. The right inferior pulmonary vein
(RIPV) has the lowest proportion of initial AF trig-
gers, but the highest proportion of new triggers on
repeat study among patients with recurrent AF (6).
he RIPV also stands out technically as the most
ifficult vein to ablate, due to poor catheter access
4,16,17).
High spatial resolution 3-dimensional (3D) late
adolinium enhancement (LGE) CMR (18,19) al-
ows for noninvasive detection of left atrial (LA)
blation sites in patients with AF (7). The scar is
bserved as an accumulation of gadolinium contrast.
e hypothesized that a greater volume of scar, and
ore circumferentially distributed scar, would lead to
reater clinical success. Therefore, we studied the
elationship of the volume and the distribution of
GE surrounding each vein to treatment success.
M E T H O D S
Patients. Between April 2005 and May 2007, we
canned 59 consecutive patients after their first
adiofrequency (RF) ablation for AF. From these,
e excluded patients with suboptimal image quality
n  24) (41%). The remaining 35 consecutive pa-
ients were enrolled in our imaging study (Table 1). phe study was approved by the hospital committee
n clinical investigations.
PV isolation procedure and documentation of re-
currence. The circumferential PV isolation proce-
dure has been described elsewhere (20). Briefly, an
8-mm (n  29) standard tip or a 3.5-mm (n  6)
xternally irrigated tip ablation catheter was used
or ablation, advanced through a Mullins sheath
nto the LA. A circumferential catheter, advanced
hrough a second Mullins sheath, was placed at
ach PV ostium to guide ablation and to confirm
V entrance and exit block (21). The RF ablations
ere placed 5 to 10 mm outside of each PV ostium
ntil electrical PV isolation was achieved. For the
-mm catheter, the maximum temperature setting
as 52°, and maximum power output was 50 W; for
he 3.5-mm catheter, power was limited to
0 W. Ablation was performed for 30 to
20 s at each site, based on changes in
ocal electrograms. All PVs were routinely
solated in all patients, without routine
ddition of empiric ablation lines in the
A. As part of our standard method of
tepwise ablation, in 8 patients with in-
ucible atrial tachyarrhythmias, 1 or more
dditional ablation lines were made. In 6
atients ablation was performed from the
IPV inferiorly and anteriorly to the mi-
ral annulus (the “mitral isthmus”) for LA
utter; in 2 patients, ablation was created
long the LA “roof,” from the left superior
ulmonary vein (LSPV) to the right supe-
ior pulmonary vein (RSPV). In 3 pa-
ients, ablation was created at the superior
ena cava-right atrium junction for persis-
ently inducible AF after LA ablation had
een completed. Catheter manipulation
as guided by fluoroscopy, intracardiac
ltrasound, and 3D electroanatomic mapping sys-
ems (CARTO [Biosense Webster, Diamond Bar,
alifornia] and/or NAVx [Endocardial Solutions,
t. Paul, Minnesota]). A single highly experienced
perator (M.E.J.) performed 33 of 35 (94%) of the
F ablation procedures. Post-procedure, patients
ere monitored for recurrence of AF using an event
onitor for 2 weeks post-procedure; and they were
cheduled to undergo mobile outpatient cardiac
elemetry monitoring for 7 days at 1, 6, and 12
onths post-procedure.
Recurrent AF was defined as any symptomatic or
symptomatic episode lasting longer than 10 s,
ccurring more than 30 days after the ablation
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310recent follow-up were used to construct survival
curves.
CMR imaging of RF ablation sites. CMR was per-
ormed 30 to 60 days after the PV isolation proce-
ure using a Philips 1.5-T CMR scanner (Achieva,
hilips Healthcare, Best, the Netherlands), 20 to 25
in after administration of 0.2 mmol/kg Gd-
TPA (Magnevist, Berlex Laboratories, Wayne,
ew Jersey), using a 3D LGE CMR sequence as
reviously described (7,22,23). Technical scan pa-
ameters included 3D inversion recovery gradient
cho sequence, 1 RR interval between inversions,
epetition time (TR)/echo time (TE)/flip angle ()
5.3 ms/2.1 ms/25°, 32  32  12.5 cm field-of-
iew, 250 Hz/pixel receiver bandwidth, matrix 224
224  23 to 32 Nz, average inversion time (TI)
280 ms, 1.4 1.4 4 to 5 mm spatial resolution
econstructed to 0.6  0.6  2 to 2.5 mm spatial
esolution. Electrocardiogram triggering (150 ms
nd-diastolic window), navigator gating, and fat
uppression were employed during the 4- to 8-min
can time.
Data analysis. Analyses of the extent of scarring of
he PVs and LA were performed using 2 metrics: a
uantitative measure of scar volume in each PV
egion and a qualitative visual measure of scar
ircumferentiality. These measurements were com-
ared with the clinical outcome of AF recurrence
n follow-up.
QUANTITATIVE SCAR VOLUME MEASUREMENT. Im-
age processing was performed in Matlab 7.1 (Math-
works, Natick, Massachusetts) by a blinded ob-
server (D.C.P.). To regionally quantify scar for each
Table 1. Subject Characteristics
All Subjects
(n  35)
Age (yrs) 56  13
Male gender (%) 31 (88)
Paroxysmal AF* (%) 17 (49)
Persistent AF (%) 10 (28)
Permanent AF (%) 8 (23)
Heart rate (beats/min)/% in SR 62/89%
LA volume (ml/m2) 63  17
Valvular heart disease (%) 2 (6)
Any mitral regurgitation (%) 19 (54)
Hypertension† (%) 15 (43)
LV ejection fraction 0.57  0.08
Total RF ablation time (s) 3,600  1,000
RF ablation number by CARTO‡ 145  47
*p  0.002; †p  0.015; ‡p  0.04, all others p  NS.
AF  atrial ﬁbrillation; LA  left atrial; LV  left ventricular; RF  radiofrequeslice in the 3D volume (Fig. 1), the pixels contain-ing hyperenhanced regions were identified using
thresholding. A patient-specific threshold was cho-
sen by visually comparing the results of multiple
thresholding values to the scarred region in the
original image. The minimum threshold that elim-
inated most LA blood pool pixels was chosen. After
thresholding, isolated high signal intensity voxels
were removed. Within the LA, each pixel was
classified as belonging to 1 (or more) of 5 areas:
LIPV, LSPV, RIPV, RSPV, and LA posterior wall.
The classification of scarred voxels was made by
drawing regions of interest (ROIs) in each slice
encompassing each area of the LA (Fig. 1). The
total volume of scar in each region and in each slice
was measured by summation over all slices. Because
the inferior/superior PVs often share a common
branch point, the ROIs for ipsilateral inferior/
superior PV ostia often overlapped (Fig. 2B, LIPV
and LSPV, arrow). The ROIs for the posterior wall
and inferior PVs also overlap. The drawing of ROIs
and choice of thresholds add an element of subjec-
tivity to the scar volume measurement. Neverthe-
less, at our center, the inter- and intraobserver
variability for total scar volume measurement, in-
cluding choice of threshold and ROIs, have been
measured. For intraobserver variability, the coeffi-
cient of linear regression was R 0.89 with a mean
bias  standard deviation of 0.33  1.69 ml; for
nterobserver variability, R  0.88 with a bias of
0.96  1.87 ml (11).
VISUAL DISPLAY. For visual display of the scar,
the 3D LGE (Figs. 1 and 2) were registered to
contrast-enhanced magnetic resonance angio-
AF Recurrence
(n  13)
No AF Recurrence
(n  22)
55  13 57  13
12 (92) 19 (86)
2 (15) 15 (68)
6 (46) 4 (18)
5 (38) 3 (14)
69/69% 57/100%
65  22 61  12
1 (8) 1 (5)
7 (54) 12 (54)
9 (69) 6 (27)
0.56  0.08 0.58  0.09
3,500  1,000 3,600  1,000
166  45 129  42
SR  sinus rhythm.graphic images (24) of the same patient, using
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311scaling of voxel sizes and translation in the x, y, and
z directions. The rigid registration was performed
using landmarks and recorded image coordinates.
The registered scar images, after thresholding and
masking to include only scarred pixels, were com-
bined with the magnetic resonance angiogram, and
the resulting images were surface rendered to visu-
alize the scar in 3D.
QUALITATIVE ASSESSMENT. An experienced reader
ith 1.5 years clinical CMR/LGE experience,
linded to outcome, graded the circumferentiality of
car around each PV using a pre-established grad-
ng system, on a scale of 1 (no LGE or only 1
uadrant of a PV ostium with LGE) to 3 (extensive
carring and 3 quadrants with LGE) using the
ource 3D data sets and a public domain image
iewer (ImageJ 1.37v, National Institutes of Health,
ethesda, Maryland). A second experienced reader
ndependently analyzed the data to provide a mea-
ure of interobserver variability. Due to the known
echnical difficulty in ablating the RIPV, the infe-
ior portion of the RIPV ostia was analyzed as to
he presence or absence of scar. Finally, the visibility
f additional ablation lines on the LGE images was
lso assessed in an unblinded fashion. Pre-ablation
A volumes were measured at end-systole, by
lanimetering magnetic resonance functional im-
ges of the LA in the 2- and 4-chamber views
11,25), with indexing to body surface area.
Statistics. Continuous measurements are presented as
Figure 1. Methodology for Measuring Scar Volumes
(A) Original late gadolinium enhancement images of scar with hyperen
separating scar from normal tissues. (C) Regions of interest (ROIs) are u
nary vein (LIPV), right inferior pulmonary vein (RIPV), left superior pulm
slice is analyzed using thresholding ands ROIs to identify scarred pixelsean  standard deviation and were compared using nthe Wilcoxon rank sum test. Categorical variables are
expressed as numbers and percentages and were com-
pared using Fisher exact test. Where appropriate,
Bonferroni correction was used to correct for multiple
testing. Estimated AF-free survival was calculated
using the product-limit method (Kaplan-Meier anal-
ysis) with comparison of strata using the log-rank test.
The relationship of RIPV scar with the recurrence of
AF was further assessed using proportional hazards
regression. The natural log transformation of RIPV
scar was used in this analysis because the data were not
normal. A 2-sided value of p  0.05 was considered
significant. Statistical analyses were performed using
SAS for Windows (version 9.1, SAS Institute Inc.,
Cary, North Carolina) or Stata IC 10 (StataCorp,
College Station, Texas).
R E S U L T S
Subjects were followed for 6.7 3.6 months after RF
ablation. Clinical recurrence of AF was noted in 13
patients (37%), with an average time to recurrence of
109  75 days. Eight of the 13 patients (62%) with
AF recurrence had symptomatic improvement, de-
fined as90% reduction in symptoms. Twelve of the
5 patients (34%) were treated with antiarrhythmic
edications, after the RF ablation. Patients with and
ithout recurrence were similar in age, gender, LA
olume, left ventricular ejection fraction, and total RF
blation times (Table 1). Hypertension (p  0.015),
ced scar. (B) Scar is highlighted (in red) using signal thresholding,
to identify scar on each slice as belonging to the left inferior pulmo-
ry vein, right superior pulmonary vein, and posterior wall. (D) Each
each region. (E) Total scar is summed over all slices.han
sed
onaonparoxysmal versus paroxysmal AF (p  0.002),
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312and a greater number of ablations as recorded by the
CARTO system (p  0.04) were all associated with
ecurrent AF (26,27).
Study of post-ablation LGE. Figure 2 shows images
from 3 patients, including a source image and a
planar reformat. The reformats show examples of
complete (Fig. 2A), partial (Fig. 2B), and minimal
(Fig. 2C) ablations of the RIPV. Figure 2D pre-
sents a 3D volume rendering of the magnetic
resonance angiogram, overlaid with segmented scar,
for 1 patient. This 3D method of visual display is
useful for appreciating the scar circumferentiality. A
3D movie of scar fused with the MR angiogram is
provided as a supplement (Online Video 1).
Table 2 compares the quantitative results for scar
volume. In all regions, except the LIPV, there was
less scar among the group of patients with AF
recurrence, with a significant difference found for
the RIPV. AF-free survival was significantly asso-
Figure 2. 3-Dimensional LGE Images in 3 Patients, With a Volum
Three patients, 2 without recurrence of atrial ﬁbrillation (A and B) a
gadolinium enhancement (LGE) slice from the 3-dimensional (3D) v
ostia. The orientation is shown in bottom panel B. The reformats p
plete; (B) 2: partial; and (C) 1: no scar. (D) A 3D volume-rendering o
(Online Video 1). A  anterior; AAo  ascending aorta; Ao  aorta
nary vein; p  posterior; RA  right atrium; RSPV  right superiorciated with RIPV scar (p  0.03) (Fig. 3).The qualitative results are shown in Table 3.
RIPV scar was lower in the recurrent versus non-
recurrent patient groups. The LIPV was more fully
scarred in nonrecurrent patients, and this trended
toward significance. The interobserver qualitative
agreement was 66%, with a kappa value of 0.46,
showing moderately good agreement.
All 6 (100%) mitral isthmus ablation lines were
visualized. Both (100%) of ablation lines across the
LA roof were visualized. Two of 3 (66%) lines
extending around the superior vena cava were ob-
served in the images. Figure 2D shows a mitral
isthmus line in 1 patient (arrow).
Using a qualitative score of 3 to indicate a fully
circumferential ablation, we found that 2.2 (55%
assuming 4 PVs) veins in patients without AF
recurrence and 1.4 (35%) veins in patients with AF
recurrence were fully ablated (Table 4). Ablation in
the inferior portion of the RIPV ostia was a
endered View
1 with recurrence of atrial ﬁbrillation (C). Top panels show a late
e. Bottom panels show planar reformats across pulmonary vein
de examples of qualitative gradings for the RIPV of (A) 3: com-
e scar for Patient B. A mitral isthmus line is observed (arrow)
foot; H  head; LA  left atrium; LSPV  left superior pulmo-
onary vein; other abbreviations as in Figure 1.e-R
nd
olum
rovi
f th
; F 
pulmsignificant predictor of recurrence (p  0.025). The
1.
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313multivariate analysis of significant univariate pre-
dictors of recurrence (paroxysmal AF and RIPV
scar volume) by Cox regression is shown in Table 5.
D I S C U S S I O N
In this study of 35 AF patients undergoing their
first RF ablation, our data demonstrate that the
extent of LA scar, especially RIPV scar, assessed
qualitatively and quantitatively by LGE CMR,
predicts AF recurrence after catheter ablation for
AF. Overall, the LIPV displayed the most circum-
ferential LGE, followed by the RIPV, the LSPV,
and the RSPV. The results are consistent with other
studies showing that AF recurrence is associated
with electrical reconnection in 1 or more PV, since
incomplete scarring may be the cause of electrical
reconnection. Yamada et al. (28) studied patients
undergoing a second ablation, where only 40% of
PVs were still electrically isolated using mapping,
including 36% of LSPVs, 36% of RSPVs, 50% of
LIPVs, and 50% of RIPVs, in good agreement with
our data on PV scar in patients with recurrent AF.
Verma et al. (5) found, in patients having a repeat
electrophysiological study, that the number of re-
connected veins was 2.0 (on average) for patients
with recurrence, and only 0.2 for patients without
recurrence; the culprit veins were not identified. In
comparison, our study found that the number of
noncircumferentially ablated veins was 2.6 (on av-
erage) for patients with recurrence, but only 1.8 for
patients without recurrence.
Early recurrence, while strongly predictive, is
not always followed by later recurrence (29,30),
suggesting that healing occurs after RF ablation.
Furthermore, at the time of ablation, local tissue
edema and incomplete myocyte damage may
contribute to the appearance of acute conduction
Table 2. LA Scar Volumes as Predictors of AF Recurrence
LGE Volume
(ml)
All Subjects
(n  35)
Recurrent
(n  13)
No
Region
Total* 7.4 4.4 6.8 4.1
LIPV 2.3 1.4 2.4 1.3
LSPV 1.1 0.8 1.0 0.7
RIPV 2.1 1.2 1.6 1.0
RSPV 1.6 1.2 1.5 1.4
PW 2.2 1.7 2.1 2.3
*Note that, since regions overlap, total scar is less than sum of scar in each re
LGE  late gadolinium enhancement; LIPV  left inferior pulmonary vein; LSPV
superior pulmonary vein; PW  posterior wall; other abbreviations as in Tableblock in patients who may later develop recurrentconduction after myocardial healing (31,32). The
3D LGE method is unique and complementary
to electrophysiology studies, because it can assess
the circumferentiality of PV scar at any time
point— early or late—and provide information
noninvasively for patients with and without
recurrence.
Most operators place more emphasis on pri-
mary isolation of the superior veins; however,
upon recurrence, the superior PVs are most likely
to be reconnected (28,33). In our study, overall,
the superior PVs were less circumferentially ab-
lated than the inferior PVs (Table 3) in qualita-
tive grading and also were surrounded by a lower
volume of scar (Table 2). However, the greater
volume of scar in the lower PVs might reflect
inclusion of some adjacent posterior wall scar
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314in the measurements or the challenges of imaging
the upper PVs.
Importance of the RIPV. Both the quantitative and
ualitative analyses identified the RIPV scar as
he “lynch pin” (i.e., most highly correlated of all
V measurements to clinical success). This may
e due to the unique technical difficulty of com-
letely isolating the RIPV (4,16,17) resulting in
reater variability of scar in that region. Notably,
erstenfeld et al. (6) showed that upon recur-
ence the majority of new triggers arose from the
IPV. In a study of late recurrence (12
months), Mainigi et al. (34) showed that the
recurrences correlated with a reconnected or ini-
tially unisolated RIPV. In another study of pa-
tients with late recurrence, the RIPV was the
most commonly reablated during a repeat abla-
tion, followed closely by the left common vein
(35). A recent case report by Reddy et al. (36),
using 3D LGE to image LA scar after PV
isolation, found scar discontinuity in the inferior
RIPV ostia, which terminated AF when ablated
in a follow-up procedure. Very recently, a study
of patients during repeat procedures for recurrent
AF showed that sites of chronic PV reconnection
were located predominantly—and in roughly
equal proportion—around the LSPV, RSPV, and
RIPV, especially the inferior-posterior portion of
the RIPV (33). This is remarkably similar to our
findings that the LIPV is well ablated in all
Table 3. Qualitative Gradings* of the Extent of LA Scar, Separa
Region
All Subjects
(n  35)
Recurrence
(n  13)
N
LIPV 2.7 2.4
LSPV 2.1 1.9
RIPV 2.3 1.9
RSPV 2.0 1.8
*1  minimal scar; 3  circumferential scar.
Abbreviations as in Tables 1 and 2.
eins With Fully Circumferential Ablation, Determined by a Quali
All Subjects
(n  35)
Recurrent
(n  13)
Nonrecurrent
(n  22)
68% (21/31) 45% (5/11) 80% (16/20)
31% (9/29) 20% (2/10) 37% (7/19)
52% (18/35) 31% (4/13) 64% (14/22)
22/35 (63%) 4/13 (31%) 18/22 (82%)
32% (11/34) 23% (3/13) 38% (8/21)
ablated PVs 63% (22/35) 31% (4/13) 79% (15/22)
d PVs† 1.9 (48%) 1.4 (35%) 2.2 (55%)
patients with an ablation on the inferior portion of the RIPV; †also expressed as
2.patients alike and that recurrence is highly cor-
related with lack of scarring in the inferior
portion of the RIPV (31% vs. 82%). This may be
due to the difficulty in accessing this portion of
the RIPV. Previous findings, along with the
results of our study, suggest that better RF
ablation catheters and trans septal sheaths, im-
proving access to right PVs and permitting more
complete ablation of the RIPV, may reduce
recurrence rates of AF. Newer assist devices such
as steerable sheaths and remote magnetic naviga-
tion systems (37,38) may allow effective creation
of LA ablations.
Study limitations. The sample size (n  35) was
small. A larger study will help to better define the
RF ablation patterns that result in freedom from
AF. This pilot study studied the relationship of
many factors with recurrence, and the significance
of each predictor was more difficult to establish after
Bonferroni correction. The conclusions of this
study are based on procedures performed from 2005
to 2007, during which time RF ablation techniques
had been—and still are—evolving. While animal
studies have shown excellent correlation of LGE
CMR with areas of scar for myocardial infarction
(9,18), such validation for detecting scar in the
much thinner LA wall is lacking. There may be
scar, which is below the threshold of detection by
CMR, and detection of small scars may depend on
overall image quality.
by Region, as Predictors of AF Recurrence
ecurrence
 22) p Value
p Value
(Bonferroni Corrected)
2.8 0.056 0.22
2.2 0.389 NS
2.5 0.032 0.13
2.2 0.142 NS
e Grading (Grade 3)
p Value
(Recurrence vs. No Recurrence)
p Value
(Bonferroni-Corrected)
0.106 NS
NS NS
0.086 NS
0.004 0.025
NS NS
0.043 0.255
NS NS
ent assuming 4 pulmonary veins (PVs).ted
o R
(nTable 4. Number of V tativ
Region
LIPV
LSPV
RIPV
Inferior RIPV*
RSPV
Patients with 2 fully
Number of fully ablate
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Among patients undergoing PV isolation, AF re-
currence during the first year is associated with a
lesser degree of PV and LA scarring on 3D LGE
Table 5. Univariate and Multivariate Predictors of Time to AF R
Predictor
Univariate
Hazard Ratio
p V
(Bonferron
(log) RIPV scar volume 0.29 0.
Paroxysmal AF 0.19 0.
Abbreviations as in Tables 1 and 2.Circulation 2000;102:698–705.
1
1
1
1
1
1
1
atrial fibrillation? P
trophysiol 2004;27:and may have implications for the procedural tech-
nique used in PV isolation.
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eth Israel Deaconess Medical Center, Cardiovascular
ivision, 330 Brookline Avenue, Boston, Massachusetts
rrence Using Cox Regression
e
rrected)
Multivariable
Hazard Ratio
p Value
(Bonferroni-Corrected)
0.39 0.220
0.21 0.045CMR. This finding was significant for RIPV scar 02215. E-mail: dcpeters@bidmc.harvard.edu.R E F E R E N C E S
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